Journal of Market Access & Health Policy
Volume 3, 2015 - Issue 1
Open access
596
Views
12
CrossRef citations to date
0
Altmetric
Original Research Articles
Cost savings of anti-TNF therapy using a test-based strategy versus an empirical dose escalation in Crohn's disease patients who lose response to infliximab
Xavier RoblinDepartment of GastroenterologyUniversity Hospital of Saint Etienne, Saint-Etienne, France
, MD, Alain AttarDepartment of GastroenterologyIBD, Nutritional Support, Hôpital Beaujon, Clichy, France
, MD, PhD, Michel LamureUniversity Claude Bernard Lyon 1, Lyon, FranceCorrespondence[email protected]
, PhD, Bernard Savarieau
Nukleus Paris, France
, MD, Pierre BrunelPharmacy DepartmentUniversity Hospital of Saint Etienne, Saint-Etienne, France
, Gérard DuruUniversity Claude Bernard Lyon 1, Lyon, France
, PhD & Laurent Peyrin-BirouletInserm U954 and Department of GastroenterologyUniversité de Lorraine, Nancy, France
, MD, PhD show all
Article: 29229
|
Received 22 Jul 2015, Accepted 23 Sep 2015, Published online: 30 Oct 2015
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.